143 related articles for article (PubMed ID: 10962136)
1. Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies.
Subakir SB; Setiadi E; Affandi B; Pringgoutomo S; Freisleben HJ
Toxicology; 2000 Aug; 148(2-3):173-8. PubMed ID: 10962136
[TBL] [Abstract][Full Text] [Related]
2. Endometrial angiogenic response in Norplant users.
Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress, vitamin E and progestin breakthrough bleeding.
Subakir SB; Abdul Madjid O; Sabariah S; Affandi B
Hum Reprod; 2000 Aug; 15 Suppl 3():18-23. PubMed ID: 11041217
[TBL] [Abstract][Full Text] [Related]
4. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
[TBL] [Abstract][Full Text] [Related]
6. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
[TBL] [Abstract][Full Text] [Related]
7. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
[TBL] [Abstract][Full Text] [Related]
8. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
Hickey M; Fraser I; Dwarte D; Graham S
Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
[TBL] [Abstract][Full Text] [Related]
9. Endometrial vasculature in Norplant users.
Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
[TBL] [Abstract][Full Text] [Related]
10. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
Kaewrudee S; Taneepanichskul S; Jaisamraun U; Reinprayoon D
Contraception; 1999 Jul; 60(1):25-30. PubMed ID: 10549449
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
Pritts EA; Ryan IP; Mueller MD; Lebovic DI; Shifren JL; Zaloudek CJ; Korn AP; Darney PD; Taylor RN
J Clin Endocrinol Metab; 2005 Apr; 90(4):2142-7. PubMed ID: 15623808
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA
Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
[TBL] [Abstract][Full Text] [Related]
14. Endometrial biopsy collection from women receiving Norplant.
Hadisaputra W; Affandi B; Witjaksono J; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():31-4. PubMed ID: 8982743
[TBL] [Abstract][Full Text] [Related]
15. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
Goodger AM; Rogers PA; Affandi B
Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
[TBL] [Abstract][Full Text] [Related]
16. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
Hickey M; Fraser IS
Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
[TBL] [Abstract][Full Text] [Related]
17. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
[TBL] [Abstract][Full Text] [Related]
19. Hormonal treatment for bleeding irregularities in Norplant implant users.
Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
[TBL] [Abstract][Full Text] [Related]
20. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
